Guaifenesin 600 mg NDC 25000-042

Product information

Brand name (proprietary)

Guaifenesin 600 mg

Generic name (nonproprietary)

guaifenesin 600 mg

Active ingredients

Guaifenesin — 600 mg/1

Dosage form

Tablet

Route

Oral

Labeler

MARKSANS PHARMA LIMITED

Product type

Over-the-counter drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 217780

Marketing start

Aug 23, 2023

Listing expires

Dec 31, 2026

Other FDA classes

Decreased Respiratory Secretion Viscosity (Physiologic effect)Increased Respiratory Secretions (Physiologic effect)

Identifiers

Product ID 25000-042_0af3bdb4-c1f3-4941-a1de-6e08c49849cbSPL ID 0af3bdb4-c1f3-4941-a1de-6e08c49849cbSPL set ID fedf43d0-d6d1-4f50-bbab-396701e45cb2RxCUI 310621, 636522UNII 495W7451VQUPC 0325000042127, 0325000041120, 0325000042554, 0325000041342, 0325000041755, 0325000042011, 0325000042998

Pharmacologic class

Expectorant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N425000004201 followed by a unit qualifier and the quantity Copy

Package 25000-0042-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 217780

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.